Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.01% | 176.96 | 0.7% | $1383.16m | |
| MRK | Merck & Co., Inc. | 0.66% | 92.50 | 0.7% | $1203.71m | |
| PFE | Pfizer Inc. | 0.55% | 50.94 | 0.9% | $1160.82m | |
| LLY | Eli Lilly & Co. | 1.74% | 323.14 | 1.1% | $1096.78m | |
| BMY | Bristol-Myers Squibb Co. | -0.53% | 78.28 | 1.0% | $1078.11m | |
| ABBV | AbbVie, Inc. | 0.96% | 153.95 | 1.9% | $992.07m | |
| AZN | AstraZeneca Plc | 1.65% | 67.02 | 1.0% | $451.24m | |
| SGEN | Seagen Inc. | 0.33% | 179.06 | 5.7% | $322.85m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.32% | 75.30 | 0.0% | $286.13m | |
| GSK | GSK Plc | 0.97% | 43.77 | 0.2% | $281.98m | |
| HZNP | Horizon Therapeutics Plc | 0.99% | 82.50 | 5.4% | $176.10m | |
| NVS | Novartis AG | 0.70% | 84.76 | 0.2% | $166.17m | |
| MRTX | Mirati Therapeutics, Inc. | -1.84% | 67.24 | 1.6% | $154.95m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | 0.85% | 145.64 | 0.0% | $148.67m | |
| NVO | Novo Nordisk A/S | 1.63% | 110.06 | 0.1% | $146.95m |
Company Profile
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.